Evidence map›Paper›PMID 40036345›Full record

ArticleJournal of industrial microbiology & biotechnology2024

Metagenomic mining unveils a novel GH130 enzyme with exclusive xylanase activity over a wide temperature and pH ranges.

Amr A Hemeda, Sara A Zahran, Marwa Ali-Tammam, Menna A Ewida, Mona T Kashef, Aymen S Yassin, Avishek Mitra, Noha H Youssef, Mostafa S Elshahed

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amr A HemedaDepartment of Microbiology and Immunology, Faculty of Pharmacy, Future University in Egypt, 12311 Cairo, Egypt.ORCID 0000-0002-4425-565X
Sara A ZahranDepartment of Microbiology and Immunology, Faculty of Pharmacy, Future University in Egypt, 12311 Cairo, Egypt.ORCID 0000-0001-7365-6615
Marwa Ali-TammamDepartment of Microbiology and Immunology, Faculty of Pharmacy, Future University in Egypt, 12311 Cairo, Egypt.ORCID 0000-0003-2485-8100
Menna A EwidaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Future University in Egypt, 12311 Cairo, Egypt.
Mona T KashefDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0002-2505-4959
Aymen S YassinDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0002-4423-164X
Avishek MitraDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74074, USA.
Noha H YoussefDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74074, USA.ORCID 0000-0001-9159-3785
Mostafa S ElshahedDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74074, USA.ORCID 0000-0002-1067-1647

Funding

Vascular-macrophage crosstalk in GBM immunosuppressionP20GM134973 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Jimmy D. Ballard · 2020 to 2026
$17.6M
The adolescent microbiome-gut-brain axis as a potential target in opioid abuse disordersP20GM152333 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI Crystal Nicole Johnson · 2024 to 2026
$8.7M
NIGMS NIH HHS P20 GM134973NIGMS NIH HHS P20 GM152333NIH HHS P20GM134973United States Agency for International DevelopmentUS National Institutes of Health P20GM152333
6 · The paper itself

Abstract

The equine gut harbors a diverse microbial community and represents a rich source of carbohydrate-active enzymes (CAZymes). To identify and characterize potentially novel CAZymes from a horse's hindgut metagenome, shotgun metagenomic sequencing was performed on DNA extracted from a stool sample of a male horse, followed by CAZyme annotation. Here, we report on the characterization of a novel enzyme (AH2) that was identified, synthesized, cloned, and characterized from the obtained CAZyme dataset. AH2 was identified as a GH130 family member and displayed exclusive xylanase activity, a trait hitherto unreported in prior characterization of GH130 CAZymes. AH2 displayed an optimal activity at a pH of 5.6 and a temperature of 50°C. AH2 maintained significant activity across a pH range of 4-10 (62-72%) and temperatures of 30-70°C (77-86%). The enzyme had remarkable stability, with minimal reductions in activity across a temperature range of 4-70°C and pH levels of 3, 7, and 9. Docking studies identified AH2's amino acids (Glu90 and Glu149) to be involved in substrate binding. Molecular dynamics simulation confirmed the structural stability of AH2 at pH 5.6 and 50°C, further supporting its resilience under these conditions. Our results expand on the known activities associated with the GH130 CAZyme family and demonstrate that the horse gut metagenome represents an unexplored source of novel CAZymes. ONE-SENTENCE SUMMARY: A novel activity for members of the CAZyme family GH130.

Indexed as

Endo-1,4-beta XylanasesAnimalsEnzyme StabilityFecesHorsesHydrogen-Ion ConcentrationMaleMetagenomeMetagenomicsMolecular Docking SimulationMolecular Dynamics SimulationTemperatureEndo-1,4-beta XylanasesCarbohydrate-active enzymes (cazymes)Equine hindgutGlycoside hydrolases (GHs)Xylanase

Identifiers

PMID40036345
PMCPMC11905756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.